- C84.7A is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2024 edition of ICD-10-CM C84.7A became effective on October 1, 2022.
- This is the American ICD-10-CM version of C84.7A – other international versions of ICD-10 C84.7A may differ.
ICD-10-CM C84.7A is grouped within Diagnostic Related Group(s):
- 820 Lymphoma and leukemia with major o. R. Procedures with mcc
- 821 Lymphoma and leukemia with major o. R. Procedures with cc
- 822 Lymphoma and leukemia with major o. R. Procedures without cc/mcc
- 823 Lymphoma and non-acute leukemia with other procedures with mcc
- 824 Lymphoma and non-acute leukemia with other procedures with cc
- 825 Lymphoma and non-acute leukemia with other procedures without cc/mcc
- 840 Lymphoma and non-acute leukemia with mcc
- 841 Lymphoma and non-acute leukemia with cc
- 842 Lymphoma and non-acute leukemia without cc/mcc
- 974 Hiv with major related condition with mcc
- 975 Hiv with major related condition with cc
- 976 Hiv with major related condition without cc/mcc
Applicable To
- Breast implant associated anaplastic large cell lymphoma (BIA-ALCL)
Code History
- 2021 (effective 10/1/2020): New code
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2024 (effective 10/1/2022): No change
Diagnosis Index entries containing back-references to C84.7A:
- breast implant associated (BIA-ALCL) > anaplastic large cell C84.7-